Comprehensive Cancer Genomic Profiling

Solid Tumors and Hematologic Malignancies: Our NGS panels are meticulously designed to target genomic alterations across a wide spectrum of cancers, including both solid tumors and hematologic malignancies. By covering a broad range of cancer-related genes, we can identify actionable mutations, predict therapy response, and detect resistance mechanisms.

​

Precision Oncology: The insights gained from our NGS analysis support the principles of precision oncology, allowing healthcare providers to tailor treatments based on the specific genetic makeup of each patient's cancer. This includes the selection of targeted therapies, evaluation of eligibility for clinical trials, and the avoidance of treatments with likely resistance.

Advanced Biomarker Identification

Targeted Therapy and Immunotherapy Predictors: We identify biomarkers that can predict the effectiveness of targeted therapies and immunotherapies, including PD-L1 expression, microsatellite instability (MSI), and tumor mutational burden (TMB). These biomarkers are essential for optimizing therapeutic strategies and improving patient selection for specific treatments.

​

Comprehensive Mutation Profiling: Our NGS panels provide a detailed profile of genetic alterations, including single nucleotide variants (SNVs), insertions and deletions (indels), copy number variations (CNVs), and gene fusions. This comprehensive mutation profiling enables a deeper understanding of the tumor's genomic landscape.

Streamlined Workflow for Rapid Results

Rapid Turnaround Times: Understanding the urgency of cancer diagnosis and treatment, we prioritize rapid turnaround times without compromising the quality or depth of our analysis. Our streamlined workflow ensures that healthcare providers receive timely, actionable results.

​

Integration with Clinical Practice: We work closely with oncologists, pathologists, and other healthcare professionals to ensure our diagnostic services are seamlessly integrated into clinical practice. Our reports are designed to be clear and actionable, facilitating easy interpretation and quick decision-making.

Collaborative Support and Education

Genetic Counseling and Interpretive Support: Phronetik provides genetic counseling and interpretive support to healthcare providers, assisting in the understanding of complex NGS reports and the implications for patient care. Our team of experts is available to discuss results and provide guidance on treatment options.

​

Continuing Education and Training: Recognizing the rapidly evolving nature of genomic medicine, we offer continuing education and training for healthcare professionals to stay abreast of the latest developments in cancer genomics and NGS technologies.